Oxygen-rich perfusate that is compatible with optical assessments of myocardial physiology

与心肌生理学光学评估兼容的富氧灌注液

基本信息

  • 批准号:
    9252529
  • 负责人:
  • 金额:
    $ 19.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-07-01 至 2019-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The isolated perfused heart is a useful model for studying cardiac mechanics, metabolism, and electrophysiology. Its critical disadvantage is that crystalloid-based perfusate, such as Krebs-Henseleit solution (KHS), does not maintain adequate myocardial oxygenation, especially when metabolic demand is high. Perfluorocarbons (PFC) were a popular artificial O2 carrier and were actively studied for clinical use, although development has mostly ceased due to safety concerns. The loss of commercial sources of PFC emulsions detrimentally impacts the scientific community because PFC are particularly valuable for perfused heart studies and tissue engineering approaches. There is an unmet need to demonstrate that individual laboratories can make a PFC emulsion "in-house", with the goal of enabling increasingly sophisticated hypotheses of cardiac disease to be tested in adequately oxygenated perfused heart preparations. Additionally, an oxygen-rich perfusate that is compatible with fluorescence imaging, including optical mapping, will dramatically elevate the physiological significance of such studies, especially as optical mapping systems evolve to enable mapping in contracting hearts -- preparations that have a very high oxygen demand. Demonstrating that PFC perfusate maintains myocardial oxygenation and provides oxygen reserve while not substantially interfering with visible-light optical assessments of myocardial function will surely establish a new paradigm for excised heart studies. Our objective is use a custom-made PFC emulsion to provide oxygen reserve in perfused heart studies and reestablish physiological coronary flow rates, such that myocardial metabolism, in-situ mitochondrial function, and electrophysiology can be studied without physiological artifacts associated with inadequate oxygenation, such as KATP channel activation and vasodilation. We will also use a novel motion-tracking optical mapping approach to elucidate the effects of PFC-based oxygenation on sarcolemmal KATP channel activation (via APD changes), heart rate, and conduction velocity in fully working isolated rabbit heart preparations. Our primary goal is to rigorously show that a PFC-based perfusate and optical mapping with motion tracking is a powerful combination for studying energetics and electrophysiology in excised hearts. The first Aim is to determine the PFC concentration (weight/vol) that is required to maintain myoglobin oxygenation and oxidation of the ETC for excised hearts that are arrested, contracting, and working. The second Aim is to measure the effect of PFC on the fluorescence signal attenuation of several common fluorophores, including di-4-ANEPPS, RH237, Rhod- 2AM, and BCECF. The third Aim is to optically map changes in APD and CV before and after PFC perfusion in excised biventricular working hearts. Approaches developed in this project could be applied in any perfused organ experiment, having specific and substantial impact on basic whole-heart research.
 描述(申请人提供):分离的灌流心脏是研究心脏力学、新陈代谢和电生理学的有用模型。它的主要缺点是以晶体为基础的灌流液,如Krebs-Henseleit溶液(KHS),不能维持足够的心肌氧合,特别是当代谢需求较高时。全氟化碳(PFC)是一种流行的人工O2载体,临床应用研究很活跃,尽管出于安全考虑,开发大多已停止。PFC乳剂商业来源的丧失对科学界造成了不利影响,因为PFC对于灌流心脏研究和组织工程方法特别有价值。还有一种尚未得到满足的需求,那就是证明各个实验室可以“内部”制造PFC乳剂,目标是使日益复杂的心脏病假说能够在充分充氧的灌流心脏制剂中进行测试。此外,与荧光成像兼容的富氧灌流液,包括光学测绘,将极大地提高此类研究的生理意义,特别是随着光学测绘系统的发展,能够对收缩的心脏进行测绘--这是一种具有非常高氧气需求的制剂。证明PFC灌流液在维持心肌氧合和提供氧气储备的同时,不会实质上干扰对心肌功能的可见光光学评估,这肯定会为体外心脏研究建立一个新的范式。我们的目标是使用定制的PFC乳剂在灌流心脏研究中提供氧气储备,并重建生理冠脉流量,以便可以研究心肌代谢、原位线粒体功能和电生理学,而不会出现与氧合不足相关的生理性伪影,如KATP通道激活和血管扩张。我们还将使用一种新的运动跟踪光学标测方法来阐明基于PFC的氧合对充分工作的离体兔心脏标本的肌膜KATP通道激活(通过时程变化)、心率和传导速度的影响。我们的主要目标是 严谨地表明,基于PFC的灌流和带有运动跟踪的光学标测是研究离体心脏的能量学和电生理学的强大组合。第一个目标是确定PFC浓度(重量/体积),对于停搏、收缩和工作的离体心来说,维持肌红蛋白的氧合和ETC的氧化是必要的。第二个目的是测量PFC对几种常见荧光团的荧光信号衰减的影响,包括di-4-ANEPPS、RH2 37、Rhod-2AM和BCECF。第三个目的是光学标测切除的双心室工作心脏在PFC灌注前后的时程和心动过速的变化。本项目开发的方法可应用于任何灌流器官实验,对基础全心研究具有特定和实质性的影响。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matthew W. Kay其他文献

Feasibility of Long-Distance Transfer for High Resolution Optical Mapping of Cardiac Tissue Constructs
  • DOI:
    10.1016/j.bpj.2011.11.3677
  • 发表时间:
    2012-01-31
  • 期刊:
  • 影响因子:
  • 作者:
    Nina Tandon;Luther M. Swift;Matthew W. Kay;Gordana Vunjak-Novakovic;Narine Sarvazyan
  • 通讯作者:
    Narine Sarvazyan
PO-05-140 NADH CATHETER MAPPING IDENTIFIES GAP FORMATION BETWEEN PULSED FIELD ABLATION LESIONS
PO-05-140 NADH 导管测绘识别脉冲场消融病变之间的间隙形成
  • DOI:
    10.1016/j.hrthm.2025.03.1538
  • 发表时间:
    2025-04-01
  • 期刊:
  • 影响因子:
    5.700
  • 作者:
    Rebekah Russo;Terry Ransbury;Catherine Ruffino;Bridget Alber;Omar Amirana;Narine Sarvazyan;Matthew W. Kay
  • 通讯作者:
    Matthew W. Kay
The Inter-Dependency of Local Myocardial Metabolism and Epicardial Electrical Activity during Acute Ischemia and Reperfusion
  • DOI:
    10.1016/j.bpj.2009.12.2879
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Huda Asfour;Luther M. Swift;Alta Berger;Ara Arutunyan;Narine Sarvazyan;Matthew W. Kay
  • 通讯作者:
    Matthew W. Kay
Exploring the Effects of Conduction Reserve and Ephaptic Coupling in Cardiac Cells
  • DOI:
    10.1016/j.bpj.2019.11.2733
  • 发表时间:
    2020-02-07
  • 期刊:
  • 影响因子:
  • 作者:
    Joyce Lin;Steven Poelzing;Sharon A. George;Amara Greer-Short;Matthew W. Kay
  • 通讯作者:
    Matthew W. Kay
MP-470543-008 PANORAMIC HYPERSPECTRAL OPTICAL MAPPING OF CARDIAC MEMBRANE POTENTIAL AND TISSUE TYPE IN INFARCTED HEARTS
MP-470543-008 梗死心脏中心肌膜电位和组织类型的全景高光谱光学映射
  • DOI:
    10.1016/j.hrthm.2024.03.371
  • 发表时间:
    2024-05-01
  • 期刊:
  • 影响因子:
    5.700
  • 作者:
    Grant Kowalik;Murray Loew;Emilia Entcheva;Matthew W. Kay
  • 通讯作者:
    Matthew W. Kay

Matthew W. Kay的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matthew W. Kay', 18)}}的其他基金

Novel Mechanisms that Restore Cardiac Parasympathetic Activity Limits Arrhythmias and Cardiac Dysfunction After Myocardial Infarction
恢复心脏副交感神经活动的新机制可限制心肌梗死后的心律失常和心脏功能障碍
  • 批准号:
    10366054
  • 财政年份:
    2020
  • 资助金额:
    $ 19.06万
  • 项目类别:
Novel Mechanisms that Restore Cardiac Parasympathetic Activity Limits Arrhythmias and Cardiac Dysfunction After Myocardial Infarction
恢复心脏副交感神经活动的新机制可限制心肌梗死后的心律失常和心脏功能障碍
  • 批准号:
    10604331
  • 财政年份:
    2020
  • 资助金额:
    $ 19.06万
  • 项目类别:
Novel Mechanisms that Restore Cardiac Parasympathetic Activity Limits Arrhythmias and Cardiac Dysfunction After Myocardial Infarction
恢复心脏副交感神经活动的新机制可限制心肌梗死后的心律失常和心脏功能障碍
  • 批准号:
    9981104
  • 财政年份:
    2020
  • 资助金额:
    $ 19.06万
  • 项目类别:
Hypothalamic neuron activation to blunt myocardial remodeling during chronic sleep apnea
下丘脑神经元激活可减弱慢性睡眠呼吸暂停期间的心肌重塑
  • 批准号:
    10321896
  • 财政年份:
    2018
  • 资助金额:
    $ 19.06万
  • 项目类别:
Oxygen-rich perfusate that is compatible with optical assessments of myocardial physiology
与心肌生理学光学评估兼容的富氧灌注液
  • 批准号:
    9112060
  • 财政年份:
    2016
  • 资助金额:
    $ 19.06万
  • 项目类别:
Low flow reperfusion after acute myocardial ischemia: when too little is too much
急性心肌缺血后的低流量再灌注:太少就是太多
  • 批准号:
    8454499
  • 财政年份:
    2010
  • 资助金额:
    $ 19.06万
  • 项目类别:
Low flow reperfusion after acute myocardial ischemia: when too little is too much
急性心肌缺血后的低流量再灌注:太少就是太多
  • 批准号:
    8645695
  • 财政年份:
    2010
  • 资助金额:
    $ 19.06万
  • 项目类别:
Low flow reperfusion after acute myocardial ischemia: when too little is too much
急性心肌缺血后的低流量再灌注:太少就是太多
  • 批准号:
    7889518
  • 财政年份:
    2010
  • 资助金额:
    $ 19.06万
  • 项目类别:
Low flow reperfusion after acute myocardial ischemia: when too little is too much
急性心肌缺血后的低流量再灌注:太少就是太多
  • 批准号:
    8063598
  • 财政年份:
    2010
  • 资助金额:
    $ 19.06万
  • 项目类别:
Low flow reperfusion after acute myocardial ischemia: when too little is too much
急性心肌缺血后的低流量再灌注:太少就是太多
  • 批准号:
    8238372
  • 财政年份:
    2010
  • 资助金额:
    $ 19.06万
  • 项目类别:

相似海外基金

HNDS-R: Connectivity, Inclusiveness, and the Permeability of Basic Science
HNDS-R:基础科学的连通性、包容性和渗透性
  • 批准号:
    2318404
  • 财政年份:
    2023
  • 资助金额:
    $ 19.06万
  • 项目类别:
    Standard Grant
Advancing the basic science of membrane permeability in macrocyclic peptides
推进大环肽膜渗透性的基础科学
  • 批准号:
    10552484
  • 财政年份:
    2023
  • 资助金额:
    $ 19.06万
  • 项目类别:
Computer Vision for Malaria Microscopy: Automated Detection and Classification of Plasmodium for Basic Science and Pre-Clinical Applications
用于疟疾显微镜的计算机视觉:用于基础科学和临床前应用的疟原虫自动检测和分类
  • 批准号:
    10576701
  • 财政年份:
    2023
  • 资助金额:
    $ 19.06万
  • 项目类别:
Bringing together communities and basic science researchers to build stronger relationships
将社区和基础科学研究人员聚集在一起,建立更牢固的关系
  • 批准号:
    480914
  • 财政年份:
    2023
  • 资助金额:
    $ 19.06万
  • 项目类别:
    Miscellaneous Programs
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
  • 批准号:
    FL210100071
  • 财政年份:
    2022
  • 资助金额:
    $ 19.06万
  • 项目类别:
    Australian Laureate Fellowships
Developing science communication on large scale basic science represented by accelerator science
发展以加速器科学为代表的大规模基础科学科学传播
  • 批准号:
    22K02974
  • 财政年份:
    2022
  • 资助金额:
    $ 19.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions
早期病变转化和基础科学研究协调和数据管理中心
  • 批准号:
    10517004
  • 财政年份:
    2022
  • 资助金额:
    $ 19.06万
  • 项目类别:
Basic Science Core - Imaging
基础科学核心 - 成像
  • 批准号:
    10588228
  • 财政年份:
    2022
  • 资助金额:
    $ 19.06万
  • 项目类别:
UCSF - UCB TRAC Basic Science CORE
UCSF - UCB TRAC 基础科学核心
  • 批准号:
    10674711
  • 财政年份:
    2022
  • 资助金额:
    $ 19.06万
  • 项目类别:
Basic Science Core - Biosafety & Biocontainment Core (BBC)
基础科学核心 - 生物安全
  • 批准号:
    10431468
  • 财政年份:
    2022
  • 资助金额:
    $ 19.06万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了